SBRT is a major option for the treatment of celiac pain, with low rate of adverse events and a high & durable pain control.
@lauren_henke at #SABR2025
🇪🇸First Spanish prospective study on MR-Linac in pancreatic cancer !
✅ 28 pts BRPC/LAPC, SMART 5×(40–50 Gy), 100% daily adaptation
✅ 0% ≥G3 tox
✅ LC 89%@6m, OS 74%@12m, PFS median 11.5m
👏 Congrats @GenesisCareES team & esp. Daniela 🎓—final step of her PhD! ❤️
Our “Best Of” #ASTRO25 abstract summary is out! 🦾🎯
Featuring plenaries, late-breaking abstracts, and select scientific highlights.
I'm sure we missed plenty of gems - what would you add? 👇
https://t.co/IFffOxivHH
WEBINAR RETOS ORGANIZATIVOS RADIOTERAPIA ADAPTATIVA
📆 10 de junio
🛜 Online
ℹ️ Dirigido a residentes y adjuntos interesados en #radioterapiaadaptativa
https://t.co/o00OhfKcHa
Next up at #ESTRO25 : Late Breaking Abstracts
German study of hippocampal avoidance and SIB in patients with 4-10 brain mets showed a trend towards cognitive sparing
➡️ First study to show that hippocampus avoidance during WBRT may reduce depression rates
This recent study from University of Iowa Health Care, describes the treatment strategies for 8 patients with central lung tumors using Comprehensive Motion Management on a 1.5T MR-Linac.
https://t.co/wmUUIqL8mr
@LUNGevity@Lungfoundation@Xristodouleas
We are excited to see another ISRS guideline published in the Green Journal!
"Stereotactic body radiotherapy for non-spine bone metastases: A meta-analysis and international stereotactic radiosurgery society (ISRS) clinical practice guidelines"
Co-author Dr. Alexander Louie describes the results of this important publication 👇
@DrAlexLouie
RT+TT+IT: HCC no quirúrgico
🧪 En una cohorte de 62 pacientes tratados entre junio de 2020 y junio de 2023:
✅Se alcanzó una tasa de respuesta objetiva (ORR) del 90.3%
✅Supervivencia global (OS) mediana de 26.0 meses
✅PFS mediana de 17.0 meses https://t.co/wGh31bCXE0
Congrats to @AldenDSouza3@KylieKangMD for this work on MR guided adaptive SBRT for pancreatic tumors abutting/invading organs at risk in @IJROBP. Classic teaching is to prolong fractionation and avoid SBRT for OAR abutment/invasion due to toxicity. Still true in ART era? 1/
Members of the Chinese MR Linac Consortium group recently published two interesting articles on treatment of large brain metastases and cardiac sarcoma using MRgRT.
https://t.co/Z24PsUEJ8T
https://t.co/5MBNbkHpjU
#ProgressThroughCollaboration
🚀📄Our last paper is OUT! ULTRAHYPOF. AND SIB BOOST IN BREAST CANCER
• The article has been published in Red Journal. It is part of Dr. Maia Dzhugashvili’s doctoral thesis. My sincerest congratulations
• 50 days' free access to the article 👇🏻
https://t.co/8XYndpUuXN
Target Contour Consistency During Magnetic Resonance-Guided Online Adaptive Stereotactic Body Radiation Therapy - Advances in Radiation Oncology https://t.co/lVlLNzPUpM